Journal of Immunology Research (Jan 2024)

Glucans: A Therapeutic Alternative for Sepsis Treatment

  • Jesse P. M. Viana,
  • Fernanda F. Costa,
  • Tatielle G. Dias,
  • Priscila M. Mendes,
  • Gabriel B. Copeland,
  • Willian S. Nascimento,
  • Sofia S. N. Mendes,
  • Isabella F. S. Figueiredo,
  • Elizabeth S. Fernandes,
  • Anamelia L. Bocca,
  • Márcia C. G. Maciel

DOI
https://doi.org/10.1155/2024/6876247
Journal volume & issue
Vol. 2024

Abstract

Read online

Sepsis treatment is a challenging condition due to its complexity, which involves host inflammatory responses to a severe and potentially fatal infection, associated with organ dysfunction. The aim of this study was to analyze the scientific literature on the immunomodulatory effects of glucans in a murine model of systemic infection induced by cecal ligation and puncture. This study comprises an integrative literature review based on systematic steps, with searches carried out in the PubMed, ScienceDirect, Scopus, Web of Science, and Embase databases. In most studies, the main type of glucan investigated was β-glucan, at 50 mg/kg, and a reduction of inflammatory responses was identified, minimizing the occurrence of tissue damage leading to increased animal survival. Based on the data obtained and discussed in this review, glucans represent a promising biotechnological alternative to modulate the immune response and could potentially be used in the clinical management of septic individuals.